To quantify overall effects on cellular c-MYC, N-MYC and L-MYC protein levels, human carcinoma cell lines were treated with rLon, fixed and imaged by confocal microscopy, after staining with antibodies specific for the c-MYC N-terminal domain. The gene discussed is MYCN; the disease is carcinoma.